Stay up to date with our latest news and updates

Broomfenac Rafarm is now available from Tramedico. This prescription eye drop is indicated for the treatment of postoperative ocular inflammation following cataract extraction in adults, further expanding Tramedico’s ophthalmic portfolio.

Tramedico introduces Idroflog, a new eye drop for the treatment of dry eyes.

Tramedico is proud to introduce AYZ Matrix3® — an advanced new eye drop, now part of the AYZ range.

In 2025, Tramedico is again using its annual donation to create impact beyond “a nice gesture.” We purposefully choose initiatives where our support is put to work immediately and leads to clear, measurable outcomes—so it’s never just a drop in the ocean.

Tramedico wishes everyone a healthy and inspiring 2026. Please note: we will be closed over the Christmas and New Year period and will be reachable again from Monday, 5 January.

On March 10, we were proud to be present with our stand at the OVN Congress in Den Bosch—an inspiring and successful day filled with valuable discussions and great connections!

To date, more than 1,000 general practitioners (and trainees) have participated in the online training Ocular Surface Disease (OSD): Dry Eyes and Blepharitis, organized by MedNet and Tramedico.

Each year, Tramedico has the wonderful opportunity to support a charitable cause with our annual donation. We focus on initiatives where our contribution truly makes an impact and isn’t just a drop in the ocean. This year, we are proud to announce one of those causes where we know we are genuinely making a difference.

Each year, Tramedico has the wonderful opportunity to support a charitable cause with our annual donation. We focus on initiatives where our contribution truly makes an impact and isn’t just a drop in the ocean. This year, we are proud to announce one of those causes where we know we are genuinely making a difference.

For the third consecutive time, Tramedico has been awarded the FD Gazelle Award by Het Financieele Dagblad.